Francis J. Aquila

Frank has advised on deals totaling more than $1 trillion in value, including advising on more than $150 billion in 2015 and more than $100 billion in 2019. He has been called upon by leading companies such as Amgen, Anheuser-Busch InBev, Biohaven Pharmaceuticals, Canadian Pacific, Diageo, Kering, Kraft, Novartis, United Rentals, etc., to advise them and their boards of directors on M&A, corporate governance, ESG, activism, proxy contests and a range of corporate matters.